Skip to main content
NPJ Science of Food logoLink to NPJ Science of Food
. 2025 Jun 7;9:98. doi: 10.1038/s41538-025-00465-0

Enhanced solubility and bioavailability of coenzyme Q10 via co-amorphous system using stevioside

Yingting Luo 1, Yuxin Li 1, Xuening Song 1, Yuzhuo Wang 1, Simiao Liu 1, Fazheng Ren 1,2,3, Hao Zhang 1,2,3,
PMCID: PMC12145421  PMID: 40483335

Abstract

Coenzyme Q10 (CoQ10) plays a vital role in aerobic respiration and cardiovascular diseases; however, its application is limited owing to poor water solubility. In this study, equimolar CoQ10 and stevioside (STE) formed a co-amorphous (CM) system by lyophilization, and its solubility was approximately 63 times higher than that of CoQ10. Through crystal, thermodynamic, and morphological characterization of the formula, the formation of the CM system was confirmed. The intermolecular interactions were investigated by spectroscopies. The relationship of 8 intermolecular interaction sites between the two was confirmed via molecular dynamics simulation, firmly indicating the strong intermolecular forces. Further, CM products remained stable even under accelerated storage conditions, equivalent to 1 year at room temperature. Meanwhile, the area under curve (AUC) values increased by 5 times in the in vivo bioavailability study. In conclusion, the CoQ10 was transformed into an amorphous structure by initially employing STE through intermolecular interactions to enhance solubility.

Subject terms: Health care, Chemistry

Introduction

Coenzyme Q10 (CoQ10), a yellow-orange crystalline substance, comprises a central benzoquinone component connected to a 10-unit poly-isoprene tail1. The long side chain of isoprene provides strong hydrophobicity, imparting fat solubility to CoQ10 but extremely poor water solubility. CoQ10 performs crucial physiological functions, producing energy within the mitochondria2, and acts as a good antioxidant, preventing low-density lipoprotein peroxidation in blood circulation, thus exhibiting a direct anti-atherosclerotic effect3. Further, CoQ10 supplementation is beneficial to other cardiovascular diseases, including hypertension, heart failure, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases4,5.

CoQ10 is produced by the human body; however, the ability to synthesize CoQ10 gradually declines with age. For instance, the CoQ10 in the heart decreases by 32% and 60% at 40 and 80 years, respectively6. Further, genetics, diseases, or drugs (such as statins) could increase the demand for CoQ10; therefore, appropriate exogenous supplementation of CoQ10 is required. Currently, CoQ10 is primarily incorporated or dispersed in oil as a crystalline powder; however, it exhibits poor rheology, low melting point, and is easily affected by light, heat, and oxidation7. Thus, an improvement of its dissolution properties, oral bioavailability, and stability is required for utilization as food supplement formulations. Several studies have been carried out in this regard, involving nanotechnology8,9, embedding10, and solid dispersion technologies. However, nanotechnology and embedding technology target uninvolved crystal transformations and the loading capacity of CoQ10 was not high. Further, the research on CoQ10 solid dispersions involving crystal state transformation and solubility improvement was performed primarily using high molecular weight coformers, such as polyethylene glycol, polyvinylpyrrolidone, and hydroxypropyl methyl cellulose1113, which involves several challenges such as high moisture absorption, poor miscibility, and larger final dosage form. In contrast, a co-amorphous (CM) system is a single-phase system with small molecular coformers focused on converting insoluble substances from crystalline to amorphous states14. The system lacked a crystalline long-range ordered lattice; therefore, there was no need to overcome the lattice energy during the material dissolution process. Utilizing small molecules as coformers could lead to a smaller dose volume of the same quantity of substance, and the strong interaction forces in the system make it more stable15. Additionally, the preparation process is facile, leading to excellent applicability in improving the solubility, stability, and bioavailability of substances, thus being widely used in the solubilization of drugs16,17, plants, and food bioactive components1821. Currently, commonly used excipients include amino acids, organic acids, sugars, etc., while fewer studies have been conducted using glycosides22. And the appropriate ligands should be identified according to the chemical structure of the compounds to maintain the physical stability of co-amorphous system. Stevioside (STE) is a safe small-molecule natural food additive, exhibiting remarkable surface activity and good two-phase solubility of water and alcohol. STE shows good performance in improving the solubility of hydrophobic active substances like lutein and resveratrol2325. Furthermore, STE consists of hydrophobic steviol and hydrophilic glucose and rhamnose on either side, which is more likely to form intermolecular interactions with CoQ10 and has application potential in solubilization technology.

There are no studies on CoQ10 and STE CM for food applications; therefore, this study focused on improving CoQ10 water solubility and identifying the optimal formula via screening three preparation methods with food-grade ingredients such as STE. Additionally, X-ray diffractometer, differential scanning calorimetry, and scanning electron microscopy were used to explore the effect of CM technology on the crystal state, thermodynamics, and morphology of substances. The interactions between substances were investigated via Fourier transform infrared, Raman, and hydrogen nuclear magnetic resonance spectroscopies, along with molecular dynamics simulations. Further, the influence of the CM system on the dissolution, storage, and bioavailability of substances was evaluated.

Results

Solubility studies of CoQ10-STE mixture by different methods

The detected solubility of CoQ10 was 2.3 μg/mL. The solubility of CoQ10 in water could be ignored regardless of the incubation temperature (25 °C or 37 °C), or in the pure or oil forms, which belong to insoluble substances13,26. RE is a commonly used method in the laboratory, whereas SD and FD are feasible for practical production. STE significantly increased the solubility of CoQ10 compared to that of CoQ10 (p < 0.05), which could be attributed to several hydrogen bond donors and receptors, showing great potential for interaction with CoQ1027. The CoQ10 solubility improved as follows: FD > SD > RE (Fig. 1). Compared to that of CoQ10, the solubility of FD CoQ10 powder was 144.6 μg/mL, which showed a significant increase by 63 times (p < 0.05).

Fig. 1.

Fig. 1

Effect of an equimolar CoQ10 and STE mixture on solubility improvement by rotary evaporation (RE), freeze-drying (FD), and spray drying (SD). Data are shown as the mean ± standard deviation of triplicate independent experiments.

X-ray diffraction (XRD)

XRD is an effective tool for detecting crystallinity changes in samples28. The XRD patterns of CoQ10, STE, PM, and the FD products of equimolar CoQ10 and STE are shown in Fig. 2A. The 2θ diffraction peaks of CoQ10 were observed at 11.3°, 18.6°, 20.3°, 22.9°, 24.7°, 27.3°, 28.6°, 29.7°, 30.4°, 32.3°, and 38.2°, with two prominent peaks at 18.6° and 22.9°, consistent with the previously reported studies12. The XRD pattern of STE exhibited a halo-like diffraction peak at 16.5°, corresponding to STE in an amorphous state, consistent with the previous report24. Two primary peaks of CoQ10 were visible in PM, indicating no interactions between the two substances. The XRD pattern of FD CoQ10 showed a peakless ring halo line, which was different from that of CoQ10 and PM, indicating a co-amorphous state for equimolar CoQ10 and STE after lyophilization.

Fig. 2. Spectral and thermodynamic characterisation of CoQ10, STE, PM, and FD product at 1:1 molar ratio.

Fig. 2

A XRD patterns, B DSC curves, C FTIR spectra, and D Raman spectra of CoQ10, STE, equimolar PM, and FD products.

Differential scanning calorimetry (DSC)

DSC is used to observe the thermodynamic changes between CoQ10 and STE. The DSC maps are shown in Fig. 2B. The melting point peak of CoQ10 was at 52 °C approximately, and that of STE was at approximately 203 °C, consistent with the previously reported studies29,30. Only one melting point peak (50.8 °C) that shifted marginally to a lower temperature was observed in PM, which was found in PM of apigenin and oxymatrine31, owing to an increase in temperature resulting in the melting of individual components and formation of partial aggregates in situ32. However, the melting point peak of FD CoQ10 shifted to approximately 49 °C and was remarkably weakened compared to that of PM, owing to the crystal transition of CoQ1013.

Fourier transform infrared spectroscopy (FTIR)

FTIR indicates the interactions between substances. Figure 2C shows the characteristic peaks of CoQ10 at 2916–2963 cm−1 (saturated C-H stretching vibration), 2853 cm−1 (saturated C-O stretching vibration), 1649 cm−1 (C=O bond), 1611 cm−1 (benzene ring), 1448 cm−1 (out-of-plane C-H bending vibration), 1154–1287 cm−1 (out-of-plane C-O bending vibration on benzene ring), 1026–1110 cm−1 (C-O-C stretching vibration), and 796–877 cm−1 (C=H stretching vibration)12,13. The characteristic peaks of STE were observed at 3400 cm−1 (O-H stretching vibration), 2910 cm−1 (C-H stretching vibration), 1723 cm−1 (C=O stretching vibration), 1021–1082 cm−1 (C-O-C stretching vibration), and 890 cm−1 (C= out-of-plane bending vibration)33. The absorption peaks showed a remarkable overlap for PM, indicating no intermolecular interaction between the two9. Compared to that of PM, the CoQ10-STE CM product exhibited no considerable peak shift; however, the O-H vibration peak at 3400 cm−1 widened and weakened substantially. The peaks at 2910–2963 cm−1, 1649 cm−1, 1611 cm−1, and 1021–1082 cm−1 assigned to the C-H vibration, C=O, benzene ring, and C-O-C vibration, respectively, weakened remarkably.

Raman spectroscopy

Raman spectroscopy complements the FTIR to analyze the structural properties and interactions of samples. Figure 2D shows the Raman peaks of CoQ10 at 490 cm−1 (ring deformation), 888 cm−1 (C-O-C stretching), 1010–1163 cm−1 (C-C vibration), 1292–1448 cm−1 (CH2 deformation), 1622 cm−1 (C=C stretching), 1675 cm−1 (C=O flex), and 2857–2924 cm−1 (CH2 and CH3 flex)34. The Raman peaks of STE were observed at 542 cm−1 (C-C-O bending), 1101–1130 cm−1 (C-O stretching of C-O-C and C-OH), 1457 cm−1 (CH2 and CH3), and 1674 cm−1 (C=C stretching), which were consistent with the reported studies35. The absorption peaks of PM overlapped remarkably, consistent with the FTIR results, indicating no interaction between the two. In contrast, only three distinct peaks ascribed to C-H deformation, C=O stretching, and C-H stretching were present in the CM product, and their intensities were weaker than those of PM. Moreover, the C-H deformation peak shifted to 1457 cm−1, and the intensities of the remaining Raman peaks weakened or disappeared substantially.

Scanning electron microscopy (SEM)

SEM is used to observe the surface morphology of the sample. The upper rows in Fig. 3A–D shows that the overall morphology of the four substances was relatively consistent. The lower rows in Fig. 3E–H exhibit flat and large clumps for CoQ10 crystal, and the formation of rod-shaped, ellipsoidal, and other particles with different morphologies for STE. PM encompassed the morphologies of two substances. However, the CM product of FD CoQ10 and STE showed an irregular, flocculent state, and the particle size was considerably reduced.

Fig. 3. SEM images of CoQ10, STE, PM, and FD product at 1:1 molar ratio.

Fig. 3

A CoQ10, B STE, C 1:1 molar ratio of CoQ10-STE PM, and D their CM product, at 200 μm scale. E CoQ10, F STE, G 1:1 molar ratio of CoQ10-STE PM, and H their CM product at 50 μm scale.

Nuclear magnetic resonance hydrogen spectroscopy (1H NMR)

1H NMR analyzes the chemical shift of hydrogen atoms and deduces the form and location of interactions between substances. Fig. S1 shows the 1H NMR of CoQ10 exhibiting peaks at 5.05–5.15 ppm, 4.91–4.95 ppm, 3.95–4.00 ppm, 3.10–3.23 ppm, 1.95–2.10 ppm, and 1.55–1.77 ppm. The chemical shift deviation (Δδ) of CoQ10 and CM product was analyzed in combination with ChemDraw analysis. Compared to those of CoQ10, six hydrogen peaks of the methyl group on −O-C=C (Δδ = 0.04), and the two hydrogen peaks on the long chain of methylene near the carbonyl group (Δδ = −0.02) were marginally shifted. Three hydrogen peaks on the methyl group near the carbonyl group shifted marginally (Δδ = 0.02), whereas the remaining peaks did not show any shift. The difference in chemical shifts changed marginally at the second decimal point, indicating no chemical reaction between the two. Therefore, the CoQ10-STE CM product might interact under the lyophilized state via intermolecular forces.

Molecular dynamics (MD) simulation

MD simulation supplements the experimental data to demonstrate the interactions between molecules in a co-amorphous system28. The calculated data of PubChem reveals that CoQ10 has 4 hydrogen bond receptor sites, and STE has 11 hydrogen bond donor sites. The possible interaction between these sites was further explored via radial distribution function (RDF) analysis, wherein the horizontal coordinate represents the distance between material sites, and the vertical coordinate is the relative probability of molecular pairs or atomic pairs at this distance. Intermolecular interaction forces such as hydrogen bonds or van der Waals forces are present within a distance of 3.5 Å31. Total 8 pairs of intermolecular interactions were observed in CM products (Fig. 4), including C=O1 site of CoQ10 between O8-H, O9-H, and O10-H of STE, O2 site of CoQ10 between O6-H of STE, and C=O4 site of CoQ10 between O1-H, O3-H, O7-H, and O10-H of STE. Among these, two high probability forces were present between C=O4 of CoQ10 and O3-H of STE at 1.74 Å and 2.75 Å, respectively, indicating a large contact possibility with the smallest distance between these two sites.

Fig. 4.

Fig. 4

MD simulation of CoQ10 and STE CM product RDF diagram.

Storage stability

The stability of a co-amorphous system is a critical index, and the maintenance or transformation of crystallinity is used to evaluate its stability over time. The possible application scenarios were simulated through storage under three conditions: refrigerated (4 °C), unopened at room temperature (dry at room temperature), and long-term storage opened at room temperature environments. Accelerated environmental storage at 40 °C, 75% RH for 3 months, could be used to simulate room temperature storage at 25 °C, 60% RH for 12 months36. Figure 5A and B reveal that the CM product showed no remarkable crystal transformation in the storage environment at 4 °C and room temperature within 6 months, exhibiting good stability. Further, the appearance and morphology of the powder did not remarkably change during this period. Figure 5C shows that the CM product exhibited a little diffraction peak near 18.6° after accelerated storage for 3 months; however, a remarkable entire crystal transition was not observed, indicating that the CoQ10-STE CM product maintained excellent stability at 25 °C and 60% RH for 12 months.

Fig. 5. Storage stability XRD spectra of equimolar CoQ10-STE CM products under different storage conditions.

Fig. 5

A 4 °C, B dry room temperature, and (C) accelerated storage environment at 40 °C, 75% RH.

In vivo bioavailability study

To study the bioavailability of CoQ10 CM products, rats were given crystalline CoQ10 and CM product, and the changes in plasma CoQ10 concentration in rats within 24 h were recorded and compared, as shown in Fig. 6. Related biological parameters are listed in Table 1. The level of CoQ10 in plasma was extremely low when oral crystalline CoQ10 was used, reaching Cmax at approximately 1 h, and the values of Cmax and AUC were calculated as 50.283 ± 5.695 ng/mL and 196.456 ± 96.874 ng h/mL, respectively. In contrast, the plasma CoQ10 of oral CM product increased significantly (p < 0.05), and the Cmax and AUC values were determined to be 308.389 ± 50.250 ng/mL and 934.563 ± 247.801 ng h/mL, which increased by 6 and 5 times, respectively.

Fig. 6.

Fig. 6

Plasma concentration-time profiles of pure CoQ10 and CoQ10-STE CM products after oral administration to rats at 15 mg/kg dose (n = 5).

Table 1.

Pharmacokinetic parameters of CoQ10 after oral administration of pure CoQ10 and CoQ10-STE CM products in rats

Parameters CoQ10 CoQ10-STE CM
AUC0-24 (ng h/mL) 196.456 ± 96.874 934.563 ± 247.801*
Cmax (ng/mL) 50.283 ± 5.695 308.389 ± 50.250*
Tmax (h) 1 2

Data are expressed as mean ± standard deviation (n = 5, 15 mg/kg).

*p < 0.05, compared with crystalline coenzyme Q10 itself.

Discussion

CoQ10 offers various health benefits due to its essential role in mitochondrial energy production37. However, its poor solubility and high molecular weight limit its application and human absorption and utilization. In this study, the water solubility of insoluble CoQ10 was improved by adding equimolar STE via co-amorphous technology. And three widely used preparation methods were tested to obtain the optimum formulation. RE involves slow evaporation under reduced pressure with constant heating and mixing of substances in solution, whereas SD is rapid atomization of the solution into droplets through the nozzle and their continuous interaction with the hot air flow. The large surface area and high-temperature drive of the droplets are conducive to the interaction between substances during SD38. In contrast, FD involves rapid sublimation of water, which provides higher porosity to the powder, resulting in higher solubility. Compared to that of SD product, the FD product had a lower moisture content, which might allow their even dispersion on the surface, and the larger surface area improves their dissolution property, resulting in a higher dissolution property of hydrocortisone after FD compared to that after SD39. Similarly, our studies revealed that the freeze-dried powder exhibited the best solubility improvement, approximately 63 times higher than that of CoQ10.

In our study, the formation of co-amorphous systems was confirmed through various characterization methods. XRD and DSC analyses revealed that the freeze-dried products of CoQ10 and STE were completely transformed from crystalline to amorphous. There were no characteristic crystalline peaks in the XRD pattern, and the substance lacked a periodic molecular arrangement owing to the absence of a crystal lattice. Thus, no lattice energy needed to be overcome during the dissolution process, resulting in high solubility31. Further, the melting point of CoQ10 was considerably inhibited in the DSC thermogram, indicating good miscibility, resulting in a co-amorphous system27. SEM analysis showed remarkable changes in the morphology of freeze-dried products compared to those of CoQ10. The reduction of particle size and the increase of surface area contributed to the improved dissolution properties of the substance in a co-amorphous system40. FTIR, Raman, and 1H NMR spectroscopies inferred an intermolecular force between CoQ10 and STE, which was attributed to the hydrogen bond donor and acceptor sites of both molecules. And our results agreed with those obtained by the FTIR spectrum of the SD product of amorphous CoQ1026. Consistent with the FTIR results, the absence of Raman bands is the Raman characteristic of co-amorphous solids41. Similar experimental phenomena could be observed in the binary products of piperine and curcumin; lovastatin and irbesartan42, which confirmed the results of our spectral speculation. Hence, interactions between substances might occur, thus promoting the CoQ10 water solubility, in agreement with previous studies on amorphous lycopene43. Moreover, the MD simulations further confirmed 8 pairs of intermolecular forces between CoQ10 and STE, with high probability forces observed between specific hydrogen bond donor and acceptor sites. These action sites were consistent with the change groups obtained in the above spectrum results, The strong intermolecular interactions in CoQ10-STE CM products played an essential role in the formation and stability of the system44.

The co-amorphous freeze-dried powder formed by equimolar CoQ10 and STE exhibited excellent storage stability. At simulated room temperature and 60% RH, the amorphous state remained unchanged for up to one year. The weaker the diffraction peak, the smaller the change in solubility after the storage period45. The XRD pattern of the storage period in a co-amorphous system predicts the stability of the sample and reflects the change in the solubility of the substance. The better stability of the CM product could be attributed to the good miscibility of the two, which dispersed the CoQ10 in this co-amorphous system. Moreover, the CM product exhibited smaller particle sizes and strong intermolecular interaction, which might restrain the molecular mobility of CoQ10, thus limiting the recrystallization46.

Additionally, the Cmax and AUC values of bioavailability in vivo increased by 6 and 5 times, respectively. However, Tmax was marginally delayed to 2 h, and this phenomenon could be observed in the results of CoQ10 emulsion, CoQ10-cyclodextrin inclusions, and CoQ10 solid dispersions10,47, which could be attributed to the high dispersion of CoQ10 in STE, resulting in a slow-release effect. CoQ10 nanoparticles increased Cmax and AUC by 3 and 4 times, respectively48, whereas the remarkably increased bioavailability of co-amorphous products was ascribed to the amorphous state. Furthermore, oral bioavailability of lipophilic compounds was reported in the order solution > suspension > powder49. STE as the ligand significantly increased the solubility of CoQ10, forming a homogeneous solution, contributing to its higher bioavailability. Additionally, the reduction of CoQ10 particle size and the increase of specific surface area contributed to improved bioavailability. While the observed increase in bioavailability is noteworthy, and co-amorphous systems could offer great potential for food applications, their industrial deployment requires overcoming stability and scalability challenges.

In summary, the co-amorphous system using STE shows significant strength for enhancing the solubility and bioavailability of CoQ10. And these findings facilitate the actual production, processing, application, and expansion of CoQ10 in food. Meanwhile, STE, as a safe, environmentally friendly, and easily biosynthesised substance, presents great potential for the sustainability of the formulation. In the future, additional studies could be needed to scale up the formulation for commercial production as well.

Methods

Materials

CoQ10 (purity ≥ 98%, food grade) was purchased from Shanxi Jin KangTai Biotech Co., Ltd. (Shanxi, China). STE (purity ≥ 98%) was purchased from Shandong Pingju Biotechnology Co., Ltd (Shandong, China). Absolute ethanol was procured from Tianjin Zhiyuan Chemical Reagent Co., Ltd (Tianjin, China). Chromatography-pure acetonitrile and methanol were obtained from Beijing Mairuida Technology Co., Ltd (Beijing, China). N-propanol was purchased from Aladdin Reagent (Shanghai, China). Deuterated chloroform was purchased from Cambridge Isotope Laboratories, Inc. (Massachusetts, America), and deuteroethanol from Shanghai Yien Chemical Technology Co., Ltd. (Shanghai, China). Spectrum-pure potassium bromide was purchased from Shanghai Macklin Biochemical Technology Co., Ltd (Shanghai, China). All other reagents used were of analytical grade and obtained from Tianjin Yongda Chemical Reagent Co., Ltd (Tianjin, China).

Preparation of CoQ10-STE mixture

A binary mixture of CoQ10 and STE was prepared at a molar ratio of 1:1 via rotary evaporation (RE), freeze-drying (FD), and spray drying (SD). Specifically, CoQ10 was dispersed in absolute ethanol and heated at 50 °C to ensure complete dissolution, whereas STE was dissolved in water. The two solutions with equal molar ratios were mixed to form a clear solution. The solution was subjected to rotary evaporation at 60 °C, followed by drying in a vacuum drying oven at 50 °C45. The spray drying conditions were as follows: inlet temperature of 125 ± 5 °C, outlet temperature of 80 ± 5 °C, feed rate of 15%, and atomizing gas flow rate of 35 mm50. The freeze-drying was performed at −80 ± 10 °C for 96–168 h. The obtained samples to be measured were placed at 4 °C. The physical mixture (PM) comprises equal molar powder of two substances obtained by grinding.

Solubility studies by high-performance liquid chromatography (HPLC)

Quantitation of CoQ10. CoQ10 was dissolved in ethanol-acetonitrile-water (55:30:15, v/v, pH 4.5 adjusted by phosphoric acid). The CoQ10 content was determined by HPLC51. The chromatography was performed on a Waters XBridgeTM C8 column (4.6 × 250 mm, 5 μm) at 45 °C with 100% methanol as the mobile phase. The flow rate of the mobile phase was 1 mL/min with a 20 μL sample volume. The standard curve was drawn with 0.05–25 μg/mL CoQ10-peak area. A supersaturated solution was obtained by mixing the powder with the same volume of water. The solution was shaken in a 200 rpm water bath at 25 °C for 24 h13. The CoQ10 solubility was determined using HPLC. The optimal solubility product was selected for subsequent characterization.

X-ray diffraction (XRD)

XRD analysis was carried out by XD-3 X-ray diffractometer (PERSEE, China) with Cu radiation at room temperature. The tube voltage and amperage were set at 36 kV and 20 mA, respectively. Data for each sample were collected over the 2θ range from 5–45°10. The scanning speed was 4°/min, and the step size was 0.02°.

Differential scanning calorimetry (DSC)

DSC analysis was carried out using DSC-60 (SHIMADZU, Japan). 3–5 mg samples were placed in an aluminum crucible and heated at 10 °C/min in the 25–250 °C range with a 50 mL/min nitrogen flow rate13. The result was expressed as heat flow per unit weight of the sample (mW/mg).

Fourier transform infrared spectroscopy (FTIR)

FTIR spectra were obtained using a Frontier™ Fourier infrared spectrometer (PERIKIN ELMER, America). Each sample was scanned at a 4 cm−1 resolution for 64 scans in the 400–4000 cm−1 frequency scan range9.

Raman spectroscopy

A LabRAM HR Evolution micro confocal laser Raman spectrometer (HORIBA, France) was used at an excitation wavelength of 633 nm. The spectrum was collected in 400–3200 cm−1 range with 100% intensity.

Scanning electron microscopy (SEM)

The surface morphology of the samples was observed using the SEM SU3500 (HITACHI, Japan). Each sample was fixed to the sample table and sputter-coated using an electron microscope sputter coater equipped with a gold (Au) source before the photographs were visualized.

Nuclear magnetic resonance hydrogen spectroscopy (1H NMR)

An Avance NEO 500 M NMR spectrometer (Bruker, Germany) was used for 1H NMR analysis at room temperature. 25 mg/mL CoQ10 and highly water-soluble CoQ10 were obtained in deuterated chloroform and deuteroethanol, respectively, owing to the limited solubility of the molecules.

Molecular dynamics (MD) simulation

CoQ10 and STE formula were downloaded from PubChem (https://pubchem.ncbi.nlm.nih.gov/) using Material Studio 2019 geometric structure optimization, and the maximum number of iterations was set to 10,000 with the amorphous cell code. CoQ10 and STE CM systems in cubic cells with periodic boundary conditions were constructed in a 1:1 molar ratio. The quality parameters were fine. The reaction was simulated by isotherm-isobaric (NPT) or canonical (NVT) ensemble using a step width of 1.0 fs. The radial distribution function (RDF) was calculated and analyzed after the reaction parameters were balanced31.

Storage stability

The highly water-soluble CoQ10 mixture was placed at 4 °C, at room temperature 0% RH (containing anhydrous copper sulfate), and at 40 °C, 75% RH (containing saturated sodium chloride solution), respectively52. The powder was taken out at different time intervals and investigated via XRD analysis to observe the change in crystallinity.

In vivo bioavailability study

Six-week-old SPF-grade male SD rat (180–200 g) was purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing, China). Free drinking water and feed were provided for over 3 days at an ambient temperature of 23–25 °C, RH of 50–60%, with a light/dark cycle for 12 h. All experiments were performed per the guidelines approved by the Experimental Animal Welfare and Animal Experiment Ethics Committee of China Agricultural University (AW11304202-5-1). After the adaptation period, the rats were randomly divided into two groups (n = 5) to study the bioavailability of CoQ10 and highly water-soluble CoQ10 products. After 12 h fasting, rats were given CoQ10 (15 mg/kg) and highly water-soluble CoQ10 products (15 mg/kg) dispersed in 0.5% (w/v) sodium carboxymethyl cellulose solution13,48. 300 μL of blood was collected from the tail vein every 0, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, and 24 h. The plasma was separated via centrifugation at 5000 rpm (4 °C) for 5 min and frozen at −80 °C for further testing.

60 μL plasma was mixed with 120 μL n-propanol and swirled for 5 min before centrifugation at 12,000 rpm for 10 min. 50 μL supernatant was used for HPLC determination, as mentioned previously. 60 μL CoQ10 plasma standard solution was prepared by mixing the CoQ10 absolute ethanol solution with untreated rat plasma. The standard curve of 0–3000 ng/mL was prepared using the same treatment10. A non-compartmental pharmacokinetic model was selected, and the area under the plasma substance concentration-time curve (AUC) was estimated by the linear ladder method. The maximum concentration (Cmax) and the time required to reach the maximum concentration (Tmax) were calculated using WinNonlin 8.1 (Pharsight Co., CA, USA).

Statistical analysis

All experiments were analyzed in triplicate, and data were reported as mean ± standard deviation. The data analyses, including t-test and one-way analysis of variance with Duncan’s multiple range test within groups, were performed using SPSS 22 (SPSS Inc., Chicago, IL, USA). Differences with p < 0.05 were considered significant.

Supplementary information

Acknowledgements

This work was supported by the National Key R&D Program of China (No. 2022YFF1100402). The funders had no role in the design, analysis, or writing of this article.

Author contributions

Y.L.: Data curation, Writing - original draft; Y.L.: Formal analysis, Visualization, Software; X.S., Y.W., and S.L.: Methodology, Validation; F.R.: Resources, Investigation; H.Z.: Supervision, Writing - review & editing, Project administration, Funding acquisition. All authors reviewed the manuscript.

Data availability

No datasets were generated or analyzed during the current study.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

The online version contains supplementary material available at 10.1038/s41538-025-00465-0.

References

  • 1.Hargreaves, I., Heaton, R. A. & Mantle, D. Disorders of human coenzyme Q10 metabolism: An overview. Int. J. Mol. Sci.21, 6695 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Larsen, P. L. & Clarke, C. F. Extension of life-span in caenorhabditis elegans by a diet lacking coenzyme Q. Science295, 120–123 (2002). [DOI] [PubMed] [Google Scholar]
  • 3.Witting, P. K., Petersson, K., Letters, J. & Stocker, R. Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic. Biol. Med.29, 295–305 (2000). [DOI] [PubMed] [Google Scholar]
  • 4.Jankowski, J., Korzeniowska, K., Cieślewicz, A. & Jabłecka, A. Coenzyme Q10 – A new player in the treatment of heart failure? Pharmacol. Rep.68, 1015–1019 (2016). [DOI] [PubMed] [Google Scholar]
  • 5.Spindler, M., Beal, M. F. & Henchcliffe, C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsych. Dis. Treat.5, 597–610 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kalén, A., Appelkvist, E. & Dallner, G. Age-related changes in the lipid compositions of rat and human tissues. Lipids24, 579–584 (1989). [DOI] [PubMed] [Google Scholar]
  • 7.Arenas-Jal, M., Suñé-Negre, J. M. & García-Montoya, E. Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges. Compr. Rev. Food Sci. Food Saf.19, 574–594 (2020). [DOI] [PubMed] [Google Scholar]
  • 8.Liu, Q. et al. Characterization, antioxidant capacity, and bioaccessibility of coenzyme Q10 loaded whey protein nanoparticles. LWT160, 113258 (2022). [Google Scholar]
  • 9.Shi, Y., Ye, F., Chen, Y., Hui, Q. & Miao, M. Dendrimer-like glucan nanoparticulate system improves the solubility and cellular antioxidant activity of coenzyme Q10. Food Chem.333, 127510 (2020). [DOI] [PubMed] [Google Scholar]
  • 10.Hatanaka, J., Kimura, Y., Lai-Fu, Z., Onoue, S. & Yamada, S. Physicochemical and pharmacokinetic characterization of water-soluble coenzyme Q10 formulations. Int. J. Pharm.363, 112–117 (2008). [DOI] [PubMed] [Google Scholar]
  • 11.Bhandari, K. H. et al. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. Biol. Pharm. Bull.30, 1171–1176 (2007). [DOI] [PubMed] [Google Scholar]
  • 12.Choi, J., Park, J. & Park, J. Design of coenzyme Q10 solid dispersion for improved solubilization and stability. Int. J. Pharm.572, 118832 (2019). [DOI] [PubMed] [Google Scholar]
  • 13.Lamichhane, S. et al. Enhancing solubility and bioavailability of coenzyme Q10: formulation of solid dispersions using Soluplus® as a carrier. Arch. Pharm. Res.45, 29–37 (2022). [DOI] [PubMed] [Google Scholar]
  • 14.Allesø, M. et al. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen–cimetidine mixtures prepared by mechanical activation. J. Control Release136, 45–53 (2009). [DOI] [PubMed] [Google Scholar]
  • 15.Shi, Q. et al. Recent advances in enhancement of dissolution and supersaturation of poorly water-soluble drug in amorphous pharmaceutical solids: A review. AAPS PharmSciTech23, 16 (2021). [DOI] [PubMed] [Google Scholar]
  • 16.Dhore, P. W. et al. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. Pharm. Dev. Technol.22, 90–102 (2016). [DOI] [PubMed] [Google Scholar]
  • 17.Saoji, S. D. et al. The study of the influence of formulation and process variables on the functional attributes of simvastatin-phospholipid complex. J. Pharm. Innov.11, 264–278 (2016). [Google Scholar]
  • 18.Usapkar, P. et al. QbD-guided phospholipid-tagged nanonized boswellic acid naturosomal delivery for effective rheumatoid arthritis treatment. Int. J. Pharm. X7, 100257 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Saoji, S. D. et al. Phospholipid based colloidal nanocarriers for enhanced solubility and therapeutic efficacy of withanolides. J. Drug Deliv. Sci. Tec.70, 103251 (2022). [Google Scholar]
  • 20.Saoji, S. D. et al. The role of phospholipid as a solubility- and permeability-enhancing excipient for the improved delivery of the bioactive phytoconstituents of Bacopa monnieri. Eur. J. Pharm. Sci.108, 23–35 (2017). [DOI] [PubMed] [Google Scholar]
  • 21.Saoji, S. D. et al. Preparation and evaluation of phospholipid-based complex of standardized centella extract (SCE) for the enhanced delivery of phytoconstituents. AAPS J.18, 102–114 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shi, Q., Moinuddin, S. M. & Cai, T. Advances in coamorphous drug delivery systems. Acta Pharm. Sin. B9, 19–35 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Luo, S. et al. Hybridization of glucosyl stevioside and hydroxypropyl methylcellulose to improve the solubility of lutein. Food Chem.394, 133490 (2022). [DOI] [PubMed] [Google Scholar]
  • 24.Dai, Z. et al. Study on the bioavailability of stevioside-encapsulized lutein and its mechanism. Food Chem.354, 129528 (2021). [DOI] [PubMed] [Google Scholar]
  • 25.Wan, Z., Wang, L., Yang, X., Wang, J. & Wang, L. Controlled formation and stabilization of nanosized colloidal suspensions by combination of soy protein and biosurfactant stevioside as stabilizers. Food Hydrocoll.52, 317–328 (2016). [Google Scholar]
  • 26.Chan, S. W. et al. Emulsion formulation optimization and characterization of spray-dried κ-carrageenan microparticles for the encapsulation of CoQ10. Food Sci. Biotechnol.25, 53–62 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Borde, S. et al. Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin. J. Drug Deliv. Sci. Tec.64, 102564 (2021). [Google Scholar]
  • 28.Tantishaiyakul, V., Suknuntha, K. & Vao-Soongnern, V. Characterization of cimetidine–piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations. AAPS PharmSciTech.11, 952–958 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Inoue, Y., Nanri, A., Murata, I. & Kanamoto, I. Characterization of inclusion complex of coenzyme Q10 with the new carrier CD-MOF-1 prepared by solvent evaporation. AAPS PharmSciTech.19, 3048–3056 (2018). [DOI] [PubMed] [Google Scholar]
  • 30.Khattab, S. N., Massoud, M. I., El-Razek, A. M. A. & El-Faham, A. Physico-chemical and sensory characteristics of steviolbioside synthesized from stevioside and its application in fruit drinks and food. J. Food Sci. Technol.54, 185–195 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li, B. et al. Apigenin-oxymatrine binary co-amorphous mixture: Enhanced solubility, bioavailability, and anti-inflammatory effect. Food Chem.373, 131485 (2022). [DOI] [PubMed] [Google Scholar]
  • 32.Telange, D. R. et al. Formulation and characterization of an ternary amorphous-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. Eur. J. Pharm. Sci.108, 36–49 (2017). [DOI] [PubMed] [Google Scholar]
  • 33.Xu, Y. et al. Study on physicochemical characteristics of lutein nanoemulsions stabilized by chickpea protein isolate-stevioside complex. J. Sci. Food Agric.102, 1872–1882 (2022). [DOI] [PubMed] [Google Scholar]
  • 34.Veij, M. D., Vandenabeele, P., Beer, T. D., Remon, J. P. & Moens, L. Reference database of Raman spectra of pharmaceutical excipients. J. Raman Spectrosc.40, 297–307 (2009). [Google Scholar]
  • 35.Jentzsch, P. V., Torrico-Vallejos, S., Mendieta-Brito, S., Ramos, L. A. & Ciobotă, V. Detection of counterfeit stevia products using a handheld Raman spectrometer. Vib. Spectrosc.83, 126–131 (2016). [Google Scholar]
  • 36.Grimm, W. Extension of the International Conference on Harmonization tripartite guideline for stability testing of new drug substances and products to countries of climatic zones III and IV. Drug Dev. Ind. Pharm.24, 313–325 (1998). [DOI] [PubMed] [Google Scholar]
  • 37.Bhagavan, H. N. & Chopra, R. K. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion7, S78–S88 (2007). [DOI] [PubMed] [Google Scholar]
  • 38.Šalamúnová, P. et al. Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs. Eur. J. Pharm. Biopharm.168, 15–25 (2021). [DOI] [PubMed] [Google Scholar]
  • 39.Dontireddy, R. & Crean, A. M. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Dev. Ind. Pharm.37, 1141–1149 (2011). [DOI] [PubMed] [Google Scholar]
  • 40.Seo, S., Han, H., Chun, M. & Choi, H. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. Int. J. Pharm.424, 18–25 (2012). [DOI] [PubMed] [Google Scholar]
  • 41.Heinz, A., Strachan, C. J., Gordon, K. C. & Rades, T. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. J. Pharm. Pharmacol.61, 971–988 (2009). [DOI] [PubMed] [Google Scholar]
  • 42.Wilhelm-Romero, K. et al. Evaluation of piperine as natural coformer for eutectics preparation of drugs used in the treatment of cardiovascular diseases. AAPS Pharmscitech.23, 127 (2022). [DOI] [PubMed] [Google Scholar]
  • 43.Li, D., Li, L., Xiao, N., Li, M. & Xie, X. Physical properties of oil-in-water nanoemulsions stabilized by OSA-modified starch for the encapsulation of lycopene. Colloids Surf. A.552, 59–66 (2018). [Google Scholar]
  • 44.Hu, D. et al. Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability. Int. J. Pharm.635, 122707 (2023). [DOI] [PubMed] [Google Scholar]
  • 45.Nepal, P. R., Han, H. & Choi, H. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. Int. J. Pharm.383, 147–153 (2010). [DOI] [PubMed] [Google Scholar]
  • 46.Han, J. et al. Deaggregation and crystallization inhibition by small amount of polymer addition for a co-amorphous curcumin-magnolol system. Pharmaceutics13, 1725 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Yang, R. et al. Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. Drug Dev. Ind. Pharm.44, 289–295 (2018). [DOI] [PubMed] [Google Scholar]
  • 48.Swarnakar, N. K. et al. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials32, 6860–6874 (2011). [DOI] [PubMed] [Google Scholar]
  • 49.Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.45, 2615–2623 (2002). [DOI] [PubMed] [Google Scholar]
  • 50.Bule, M. V., Singhal, R. S. & Kennedy, J. F. Microencapsulation of ubiquinone-10 in carbohydrate matrices for improved stability. Carbohydr. Polym.82, 1290–1296 (2010). [Google Scholar]
  • 51.Clementino, A. & Sonvico, F. Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin’s isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles. J. Pharm. Biomed.155, 33–41 (2018). [DOI] [PubMed] [Google Scholar]
  • 52.Wegiel, L. A., Zhao, Y., Mauer, L. J., Edgar, K. J. & Taylor, L. S. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability. Pharm. Dev. Technol.19, 976–986 (2014). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

No datasets were generated or analyzed during the current study.


Articles from NPJ Science of Food are provided here courtesy of Nature Publishing Group

RESOURCES